Maryland Senate bill in Session 2026.
Status: introduced. Latest action: April 24, 2026.
Public Health - Medetomidine and Xylazine Consumer Protection Act.
Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain certain records; etc.
| Date | Event | Detail |
|---|---|---|
| 2026-01-30 | Introduced | Bill introduced |
| 2026-01-30 | Status | introduced |
| 2026-04-24 | Latest Action | In the Senate - Laid Over (Senator Ready) Adopted |